Skip to main content
Literatur
1.
Zurück zum Zitat Reid S, Yang S, Brown R et al (2010) Characterization and relevance of CD138 negative plasma cells in plasma cell myeloma. Int J Lab Hematol 32:190–196CrossRef Reid S, Yang S, Brown R et al (2010) Characterization and relevance of CD138 negative plasma cells in plasma cell myeloma. Int J Lab Hematol 32:190–196CrossRef
2.
Zurück zum Zitat Wu D, Guo X, Su J et al. (2015) CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway. Biochimica et Biophysica Acta 1853(2):338–347CrossRefPubMed Wu D, Guo X, Su J et al. (2015) CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway. Biochimica et Biophysica Acta 1853(2):338–347CrossRefPubMed
3.
Zurück zum Zitat Chen C, Masih-Khan E, Jiang H et al (2013) Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents. Br J Haematol 162(4):483–488CrossRefPubMed Chen C, Masih-Khan E, Jiang H et al (2013) Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents. Br J Haematol 162(4):483–488CrossRefPubMed
4.
Zurück zum Zitat Kawano Y, Fujiwara S, Wada N et al (2012) Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide. Int J Oncol 41:876–884CrossRefPubMedPubMedCentral Kawano Y, Fujiwara S, Wada N et al (2012) Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide. Int J Oncol 41:876–884CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Kumar S, Kimlinger T, Morice W (2010) Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract Res Clin Haematol 23(3):433–451CrossRefPubMedPubMedCentral Kumar S, Kimlinger T, Morice W (2010) Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract Res Clin Haematol 23(3):433–451CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Hosen N, Matsuoka Y, Kishida S et al (2012) CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients. Leukemia 26(9):2135–2141CrossRefPubMed Hosen N, Matsuoka Y, Kishida S et al (2012) CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients. Leukemia 26(9):2135–2141CrossRefPubMed
Metadaten
Titel
CD138 Negative Plasma Cells in Relapsed CNS Multiple Myeloma
verfasst von
Neha Singh
Jatin S. Gandhi
Narendra Agrawal
Ajit Panaych
Narender Tejwani
Anurag Mehta
Publikationsdatum
07.02.2017
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 4/2017
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0780-5

Weitere Artikel der Ausgabe 4/2017

Indian Journal of Hematology and Blood Transfusion 4/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.